Aeon has raised €8.2 million to revolutionize preventive healthcare by integrating advanced diagnostics and AI technology to enable early detection of health risks.

Target Company Information

Aeon is at the forefront of transforming preventive healthcare through its innovative technology platform. The company has successfully raised €8.2 million in funding to enhance its mission of enabling early detection of health issues through advanced diagnostics. By integrating whole-body MRI scans, advanced blood biomarkers, genetic insights, and artificial intelligence, Aeon aims to identify over 500 potential health risks often before any symptoms manifest, representing a significant advancement in proactive medical care.

The platform has already shown promising results, with 11 percent of its users receiving critical findings, all without a single false positive. Aeon's approach is not solely focused on technology; it emphasizes a commitment to saving lives by providing accurate health assessments.

Industry Overview in Target's Country

The preventive healthcare industry is rapidly evolving, particularly in Europe, where there is an increasing awareness surrounding the impact of non-communicable diseases. Every year, these diseases claim approximately 41 million l